151. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study
- Author
-
Achenbach, Chad, Egger, Matthias, Mussini, Cristina, Dronda, Fernando, Raben, Dorthe, Fätkenheuer, Gerd, Bütikofer, Lukas, Chakraborty, Rana, Konopnicki, Deborah, Meyer, Laurence, Sabin, Caroline, Miro, José M., Gill, M. John, Bonnet, Fabrice, D’Souza, Gypsyamber, Antinori, Andrea, Grabar, Sophie, Obel, Niels, Franceschi, Silvia, Chen, Yi-Ming Arthur, Barger, Diana, Kitahata, Mari M., Taylor, Ninon, Maskew, Mhairi, Law, Matthew, Brockmeyer, Norbert, Le Moing, Vincent, Clifford, Gary M., Bohlius, Julia, McGowan, Catherine, Patel, Pragna, Goedert, James J., Hasse, Barbara, Moore, Richard D., Quiros-Roldan, Eugenia, Schmidlin, Kurt, Silverberg, Michael J., Roca, Bernardino, Verbon, Annelies, Castilho, Jessica, Post, Frank A., Sengayi, Mazvita, Spagnuolo, Vincenzo, Mocroft, Amanda, Rohner, Eliane, Garone, Daniela, Paparizos, Vassilios, Giddy, Janet, and IeDEA
- Subjects
610 Medicine & health ,360 Social problems & social services ,3. Good health - Abstract
Background We compared Kaposi sarcoma (KS) risk in adults who started antiretroviral therapy (ART) across the Asia-Pacific, South Africa, Europe, Latin, and North America. Methods We included cohort data of human immunodeficiency virus (HIV)-positive adults who started ART after 1995 within the framework of 2 large collaborations of observational HIV cohorts. We present incidence rates and adjusted hazard ratios (aHRs). Results We included 208140 patients from 57 countries. Over a period of 1066572 person-years, 2046 KS cases were diagnosed. KS incidence rates per 100000 person-years were 52 in the Asia-Pacific and ranged between 180 and 280 in the other regions. KS risk was 5 times higher in South African women (aHR, 4.56; 95% confidence intervals [CI], 2.73-7.62) than in their European counterparts, and 2 times higher in South African men (2.21; 1.34-3.63). In Europe, Latin, and North America KS risk was 6 times higher in men who have sex with men (aHR, 5.95; 95% CI, 5.09-6.96) than in women. Comparing patients with current CD4 cell counts ≥700 cells/µL with those whose counts were